Bone metastasis from early gastric cancer following non-curative endoscopic submucosal dissection.
A 67-year-old male underwent endoscopic submucosal dissection (ESD) to treat early gastric cancer (EGC) in 2001. The lesion (50 mm × 25 mm diameter) was histologically diagnosed as poorly differentiated adenocarcinoma, with an ulcer finding. Although the tumor was confined to the mucosa with no evidence of lymphovascular involvement, the ESD was regarded as a non-curative resection due to the histological type, tumor size, and existence of an ulcer finding (as indicated by the 2010 Japanese gastric cancer treatment guidelines, ver. 3). Despite strong recommendation for subsequent gastrectomy, the patient refused surgery. An alternative follow-up routine was designed, which included five years of biannual clinical examinations to detect and measure serum tumor markers and perform visual assessment of recurrence by endoscopy and computed tomography scan after which the examinations were performed annually. The patient's condition remained stable for eight years, until a complaint of back pain in 2010 prompted further clinical investigation. Bone scintigraphy indicated increased uptake. Histological examination of biopsy specimens taken from the lumbar spine revealed adenocarcinoma resembling the carcinoma cells from the EGC that had been treated previously by ESD, and which was consistent with immunohistochemical findings of gastrointestinal tract cancer. Thus, the diagnosis of bone metastasis from EGC was made. The reported rates of EGC recurrence in surgically resected cases range 1.4%-3.4%, but among these bone metastasis is very rare. To our knowledge, this is the first reported case of bone metastasis from EGC following a non-curative ESD and occurring after an eight-year disease-free interval.
Endoscopy Division, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Hiroyuki
H
Kawabata
Ichiro
I
Oda
Haruhisa
H
Suzuki
Satoru
S
Nonaka
Shigetaka
S
Yoshinaga
Hitoshi
H
Katai
Hirokazu
H
Taniguchi
Ryoji
R
Kushima
Yutaka
Y
Saito
D000230:Adenocarcinoma / Q000737:chemistry / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D001859:Bone Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000556:secondary*; D002454:Cell Differentiation; D004210:Dissection; D017809:Fatal Outcome; D005743:Gastrectomy / Q000379:methods*; D005753:Gastric Mucosa / Q000473:pathology* / Q000601:surgery*; D005773:Gastroscopy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D013274:Stomach Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome
D014408:Biomarkers, Tumor
Bone metastasis; Early gastric cancer; Endoscopic submucosal dissection; Late recurrence; Non-curative resection